Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Gérard Auclerc"'
Publikováno v:
EMC - Traité de médecine AKOS. 1:1-8
Publikováno v:
EMC - Traité de médecine AKOS. 1:1-6
Autor:
Ginette Martin, Peter Harper, Pierre Banzet, David Khayat, Olivier Rixe, Jacques-André Bazex, Philippe Lauret, Gérard Auclerc, Olivier Vérola, Martine Banzet, Claude Soubrane
Publikováno v:
Cancer. 97:1941-1946
BACKGROUND This study addressed the question of whether limited surgery for primary malignant melanoma with a 2-cm margin is as good as a 5-cm margin. An update of a 16-year follow-up is provided. METHODS Nine European Centers, over a period of 5 yea
Autor:
Eric C. Antoine, Eric Vuillemin, M. Weil, Claud Soubrane, Olivier Rixe, Christopher Franks, Gérard Auclerc, A. Benhammouda, David Khayat, G. C. Ghironzi, E. Mularoni, Pierre Banzet, Christian Borel
Publikováno v:
American Journal of Clinical Oncology. 18:421-424
Tamoxifen (TAM) has been reported to enhance cisplatin (CDDP) cytotoxicity in experimental and clinical melanoma studies. Based on our previous experience with sequential cisplatin-interleukin-2 (IL2)-interferon (IFN), we performed a phase II study o
Publikováno v:
Cancer Investigation. 10:581-586
Autor:
J. P. Bizzari, G. Cohen-Alloro, J. C. Bousquet, K. Aigner, B. Audhuy, Cecil O. Borel, D. Buthiau, David Khayat, Jacquillat C, M. Weil, Gérard Auclerc, V. Cour
Publikováno v:
American Journal of Clinical Oncology. 14:400-404
Fotemustine is a new nitrosourea which has shown some efficacy on disseminated malignant melanoma (DMM) (24.2% response rate (RR) among 153 patients in a Phase II trial) but little activity on hepatic metastasis (8.8% RR). In order to improve those p
Autor:
Claude Jacquillat, David Khayat, François Baillet, Laurence Thill, Martin Housset, Christian Borel, M. A. De Maublanc, Geneviève Forget, Gérard Auclerc, Claude Soubrane, Marise Weil
Publikováno v:
Cancer. 66:119-129
Two hundred fifty evaluable patients with breast cancer entered a protocol combining neoadjuvant and consolidation therapy by vinblastine (V), thiotepa (T), methotrexate (M), and 5-fluorouracil (F) (VTMF), with or without Adriamycin (A) (doxorubicin;
Publikováno v:
Bulletin du cancer.
Thirty per cent of cancer patients suffer from anemia before any treatment. This anemia is caused by haematopoiesis troubles related to cytokines production and by endogenous erythropoietin deficiency. Clinically, its symptoms, including fatigue, spo
Autor:
Chahrok Agazia, Eric C. Antoine, Francis Cajfinger, Arlette Brunet-Pommeyrol, Gérard Auclerc, David Khayat
Publikováno v:
The oncologist. 5(1)
Most cases of advanced carcinoma of the prostate are hormonosensitive. The use of combined androgen blockade (CAB) seems to improve survival and quality of life, but only when combined with chemical castration by luteinizing-hormone-releasing hormone
Publikováno v:
American journal of clinical oncology. 20(4)